Cargando…

Skeletal malformation and the SHP-2 pathway

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2011
Materias:	In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046076/

Ejemplares similares

Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
por: Bauler, Timothy J., et al.
Publicado: (2011)

Linked defects in secretory pathways and skeletal morphogenesis
Publicado: (2011)

Venous malformations: TIEing genotype to phenotype in zebrafish
Publicado: (2011)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth
por: Fornaro, Mara, et al.
Publicado: (2006)

SHP2 Regulates Chondrocyte Terminal Differentiation, Growth Plate Architecture and Skeletal Cell Fates
por: Bowen, Margot E., et al.
Publicado: (2014)

SHP2 regulates skeletal cell fate by modifying SOX9 expression and transcriptional activity
por: Zuo, Chunlin, et al.
Publicado: (2018)

Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2–Induced Gastrulation Defects
por: Jopling, Chris, et al.
Publicado: (2007)

Functions of Shp2 in cancer
por: Zhang, Jie, et al.
Publicado: (2015)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Promoting skeletal muscle regeneration in mouse and fly models of DMD
Publicado: (2014)

Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xu, Xiaozheng, et al.
Publicado: (2021)

Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022)

Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2
por: Taylor, Julia, et al.
Publicado: (2023)

Targeted Ptpn11 deletion in mice reveals the essential role of SHP2 in osteoblast differentiation and skeletal homeostasis
por: Wang, Lijun, et al.
Publicado: (2021)

Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma
por: Beldi-Ferchiou, Asma, et al.
Publicado: (2017)

Protein-protein interaction between caveolin-1 and SHP-2 is dependent on the N-SH2 domain of SHP-2
por: Park, Hyunju, et al.
Publicado: (2015)

Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2
por: Xu, Xiaozheng, et al.
Publicado: (2020)

Intraarticular injection of SHP2 inhibitor SHP099 promotes the repair of rabbit full-thickness cartilage defect
por: Sun, Ziying, et al.
Publicado: (2022)

Destabilization of the SHP2 and SHP1 protein tyrosine phosphatase domains by a non-conserved “backdoor” cysteine
por: Yarnall, Matthew T.N., et al.
Publicado: (2022)

Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
por: Mali, Raghuveer Singh, et al.
Publicado: (2012)

Monobody Inhibitor Selective to the Phosphatase Domain of SHP2 and its Use as a Probe for Quantifying SHP2 Allosteric Regulation
por: Sha, Fern, et al.
Publicado: (2023)

The LDL Receptor-Related Protein 1 (LRP1) Regulates the PDGF Signaling Pathway by Binding the Protein Phosphatase SHP-2 and Modulating SHP-2- Mediated PDGF Signaling Events
por: Craig, Julie, et al.
Publicado: (2013)

Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca(2+)(i) signal in B cells
por: Chen, Jie, et al.
Publicado: (2016)

Phosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD–Driven AML
por: Pfeiffer, Anamarija, et al.
Publicado: (2022)

“Killer” pathway not guilty
por: Leslie, Mitch
Publicado: (2009)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

Connecting the dots between SHP2 and glutamate receptors
por: Ryu, Hyun-Hee, et al.
Publicado: (2020)

SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling
por: Niogret, Charlène, et al.
Publicado: (2019)

SHP2 is involved in the occurrence, development and prognosis of cancer
por: Li, Shu, et al.
Publicado: (2023)

Induction of dominant mutations that cause skeletal malformations in mice
por: Selby, Paul B.
Publicado: (1978)

SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia
por: Pérez-Fernández, Alejandro, et al.
Publicado: (2019)

Shp1 in Solid Cancers and Their Therapy
por: Varone, Alessia, et al.
Publicado: (2020)

Tumor Cell Dormancy and Reactivation in Bone: Skeletal Biology and Therapeutic Opportunities
por: Byrne, Niall M, et al.
Publicado: (2019)

Vitamin D and Skeletal Muscle: Current Concepts From Preclinical Studies
por: Girgis, Christian M., et al.
Publicado: (2021)

Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats
por: Zhou, Rong Ping, et al.
Publicado: (2016)

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling
por: Choi, Eunhee, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l6uadmaat2r6c92n5kdahdticp